FEMY FEMASYS INC

Nasdaq femasys.com


$ 0.88 $ 0.07 (8.58 %)    

Friday, 14-Nov-2025 15:51:12 EST
QQQ $ 608.45 $ 0.46 (0.08 %)
DIA $ 471.65 $ -2.94 (-0.62 %)
SPY $ 671.62 $ -0.11 (-0.02 %)
TLT $ 88.93 $ -0.51 (-0.57 %)
GLD $ 375.82 $ -6.91 (-1.8 %)
$ 0.8975
$ 0.75
$ 0.88 x 1,100
$ 0.89 x 1,000
$ 0.75 - $ 0.94
$ 0.31 - $ 1.80
3,624,162
na
nm
$ 0.38
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-14-2025 09-30-2025 10-Q
2 08-08-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 03-27-2025 12-31-2024 10-K
5 11-12-2024 09-30-2024 10-Q
6 08-08-2024 06-30-2024 10-Q
7 05-09-2024 03-31-2024 10-Q
8 03-28-2024 12-31-2023 10-K
9 11-14-2023 09-30-2023 10-Q
10 08-10-2023 06-30-2023 10-Q
11 05-11-2023 03-31-2023 10-Q
12 03-30-2023 12-31-2022 10-K
13 11-10-2022 09-30-2022 10-Q
14 08-10-2022 06-30-2022 10-Q
15 05-11-2022 03-31-2022 10-Q
16 03-24-2022 12-31-2021 10-K
17 11-12-2021 09-30-2021 10-Q
18 08-11-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 femasys-q3-eps-010-beats-012-estimate-sales-729394k-miss-1450m-estimate

Femasys (NASDAQ:FEMY) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.12) by 13...

 femasys-announces-start-of-post-market-surveillance-clinical-study-for-its-ce-marked-fembloc-permanent-birth-control-conducted-under-eu-medical-device-regulation-in-collaboration-with-regional-medical-experts

Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more acces...

Core News & Articles

- Reuters

Core News & Articles

https://www.youtube.com/watch?v=xagrobF4q1k 

Core News & Articles

https://www.youtube.com/watch?v=xagrobF4q1k 

Core News & Articles

https://www.nytimes.com/2025/10/16/us/politics/trump-ivf-fertility.html

 femasys-partners-with-kebomed-to-commercialize-fembloc-permanent-birth-control-in-france-and-benelux-region

Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more acce...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION